Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial

• Main Authors: Michael Horn (Author), Ulrich Behre (Author), Magali Traskine (Author), Kurt Dobbelaere (Author), Dorota Borys (Author)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2021-05-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (12vPHiD-CV) was assessed in toddlers. 12vPHiD-CV contains CRM197-conjugated capsular polysaccharides of seroty...